During the past decade, National Institute of Oncology, A Dept of Internal Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Institute of Oncology, A Dept of Internal Medicine" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "National Institute of Oncology, A Dept of Internal Medicine" are "Chronic Lymphocytic Leukemia" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "B-cell Lymphoma" (1 trials), "Chronic Lymphoid Leukemia" (1 trials) and "Diffuse Large B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "National Institute of Oncology, A Dept of Internal Medicine" in a lesser frequency.

Most popular intervention types in "National Institute of Oncology, A Dept of Internal Medicine" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (6 trials), "Cyclophosphamide" (4 trials), "Obinutuzumab" (3 trials), "Bendamustine" (2 trials) and "Doxorubicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Institute of Oncology, A Dept of Internal Medicine" are 11 trials for "All" genders.

Currently, there are NaN active trials in "National Institute of Oncology, A Dept of Internal Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in National Institute of Oncology, A Dept of Internal Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Institute of Oncology, A Dept of Internal Medicine, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".